MediBang Inc.

Based in Japan, MediBang Inc. provides digital art and content creation tools that empower creators worldwide. Their innovative platforms facilitate seamless artwork creation, sharing, and collaboration among artists. MediBang Inc.

focuses on developing digital tools for artists and was founded in 2014 in Tokyo, Japan. The company has raised a total of JPY 210. 000 mn through funding rounds, with the latest being a Series B round in October 2021. The most recent deal was with Obunsha Ventures, leading to a current company valuation of JPY 2364.

461 mn. Founder info is not available, but the company has executed 6 deals since its inception. MediBang Inc. specializes in providing innovative digital art and content creation tools aimed at empowering global creators.

The company's flagship products include the MediBang Pro and MediBang Paint applications, which are designed for digital painting and illustration. These platforms facilitate an intuitive user experience for artists, enabling them to create, share, and collaborate on artwork seamlessly. Additionally, MediBang operates the ART street platform, a community-driven space for artists to showcase their illustrations. The company serves a diverse client base that includes amateur and professional artists across various geographical markets, including North America, Europe, and Asia.

By providing comprehensive support that includes content translation and promotion on global platforms, MediBang caters to creators looking to expand their reach in the competitive landscape of manga, webtoons, games, and anime. MediBang Inc. generates revenue primarily through subscription models and direct transactions for its digital products. Clients, including individual artists and creative studios, can access premium features or tools via subscription plans tailored to their needs.

The company also engages in partnerships that facilitate broader distribution and marketing of its services. For example, MediBang Paint may be offered as a paid version with enhanced features, alongside free access to basic functionalities, encouraging a wide range of users to engage with their products. By leveraging its relationships with platforms such as the Mac and Microsoft Stores, MediBang enhances its market reach, positioning itself as a key player in the digital art industry. In October 2021, MediBang Inc.

secured a deal with Kyodo Printing Co. , Ltd. to promote the integration of real and digital content utilizing NFTs. This strategic partnership is set to enhance their offerings and explore emerging business opportunities.

The funding will support the development of new products and expansion into targeted markets, although specific geographic regions have not been disclosed. MediBang aims to leverage this investment to foster innovative solutions within the digital art landscape, aligning with evolving creator needs.